COMMUNIQUÉS West-GlobeNewswire

Regional Health Properties Reports Fourth Quarter & Full Year 2024 Financial Results
14/04/2025
ATLANTA, GA, April 14, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company”, “Regional”, “we”, “us” or “our”) (OTCQB: RHEP) (OTCQB: RHEPB) (OTCQB: RHEPA), a self-managed healthcare real estate [...]
Verano Announces Promotion and Appointment of Richard Tarapchak as Chief Financial Officer
14/04/2025
Tarapchak brings more than 30 years of accounting and finance expertise to the role CHICAGO, April 14, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading [...]
Transactions in Connection with Share Buy-back Program
14/04/2025
Company Announcement COPENHAGEN, Denmark; April 14, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce [...]
UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025
14/04/2025
Data to be presented on Monday, April 28, 2025 CORAL GABLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today [...]
Clene to Present at the Emerging Growth Conference
14/04/2025
SALT LAKE CITY, April 14, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company [...]
Can-Fite to Generate $685M in Projected Future Revenues from its Partnerships
14/04/2025
Ramat Gan, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and [...]
Happy Go Leafy Offers 20% Off on Its Red Vein Kratom Collection This Easter!
14/04/2025
Happy Go Leafy announces a limited-time Easter offer! Get 20% off on all red vein kratom items from April 14-20, 2025, with code RELAX20. Miami, Florida, April 14, 2025 (GLOBE NEWSWIRE) -- Happy Go Leafy, a pioneer in [...]
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
14/04/2025
New offering provides strategic guidance and AI-enabled biosimulation to navigate FDA’s Roadmap to Reducing Animal Testing in Preclinical Safety Studies RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. ( [...]
Longevity Health Holdings Announces Execution of Merger Agreement With 20/20 Biolabs
14/04/2025
PITTSBURGH, Pa. & GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and [...]
Can-Fite Reports 2024 Financial Results and Clinical Update
14/04/2025
Cancer-Free Survival of 8 Years in Liver Cancer Patient Treated with Namodenoson in Prior Phase II Study RAMAT GAN, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), [...]
Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products
14/04/2025
Action delays to January 1, 2026, the effective date of a Biden-era Medicare LCD for skin substitute products used to treat diabetic foot ulcers and venous leg ulcers FLORHAM PARK, N.J., April 14, 2025 (GLOBE NEWSWIRE [...]
INmune Bio Partners with Cell and Gene Therapy Catapult to Scale Up CORDStrom™ Manufacturing for Commercial Readiness
14/04/2025
Stevenage, UK, and Boca Raton, Florida, US, April 14, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune system [...]
NKGen Biotech To Present on the Use of Troculeucel for Alzheimer’s and Parkinson’s Disease at the 7th China International Biotechnology Conference & Exhibition
14/04/2025
SANTA ANA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]
HealthLynked Welcomes Anthony Scuilla as Sales Consultant to Drive Strategic Partnerships with Insurance Providers
14/04/2025
NAPLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. ( OTCQB: HLYK ), a leader in healthcare technology innovation, is proud to announce the appointment of Anthony "Tony" Scuilla as a strategic [...]
Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE)
14/04/2025
– Recognizes potential of off-the-shelf CAR T-cell therapy to address significant unmet need and enables increased dialogue with FDA throughout the development process – RMAT review by FDA included initial clinical [...]
Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise
14/04/2025
– $250 million post-close cash balance extends cash runway over two years into 2027, funding pipeline development through key data catalysts – – Coherus to focus exclusively on its innovative novel oncology programs [...]
Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization
14/04/2025
Reiterates Full-Year 2025 Guidance Arsenal Capital Partners agrees to a one-year lock-up RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, [...]
Lachine Hospital Foundation Gala raises $406,500 to support the modernization of Lachine Hospital
14/04/2025
The Lachine Hospital Foundation’s signature Gala raised an incredible $406,500 to support the Dream Big: Lachine Hospital campaign, a successful collaboration between the Lachine Hospital Foundation and the MUHC [...]
Le Gala de la Fondation de l'Hôpital de Lachine amasse 406 500 $ pour soutenir la modernisation de l'Hôpital de Lachine
14/04/2025
Le Gala signature de la Fondation de l'Hôpital de Lachine a permis de recueillir un montant impressionnant de 406 500 $ pour soutenir la campagne Oser Rêver : Hôpital de Lachine , une collaboration réussie entre la [...]

Pages